-+ 0.00%
-+ 0.00%
-+ 0.00%

AXSOME THERAPEUTICS INITIATES FORWARD PHASE 3 TRIAL OF AXS-14 FOR THE MANAGEMENT OF FIBROMYALGIA

Reuters·01/15/2026 12:00:00

Please log in to view news